Download Your Copy of the 4th Ligase Targeting Drug Development Summit Here!

Download the full event guide to examine the technical developments in the identification and validation of novel E3 ligases for previously untapped diseases in oncology and beyond. Along with nomination of novel tissue restricted E3 ligases, expand the therapeutic utility of CRBN, VHL and KLHDC2 with improved efficacy and safety.

What you can expect...

  • 80+ Attendees
  • 17 World-Class Speakers
  • 8+ Hours of Networking
  • 1 Deep Dive Workshop
  • 14 Data-Driven Presentations

*Having trouble downloading the brochure? Let us know and we’ll email it to you instead.